Ergoteles’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-76,743	Closed	-$148K	–	1893
2022 Q3	$148K	Sell	76,743 -15,057	-16%	-$29K	0.01%	1281
2022 Q2	$341K	Buy	+91,800	New	+$341K	0.01%	1037